This study found that smoking increased the risk of mortality among cancer survivors, even after adjusting for cancer type and stage,” researchers reported.

Incidence and mortality from renal cancer may double by 2050, according to a study published in European Urology.

In MIBC patients, ctDNA-guided, adjuvant atezolizumab treatment is associated with significant survival improvements over placebo.

Adjuvant ensartinib improves disease-free survival compared to placebo following complete resection of ALK-positive non-small cell lung cancer.